AI helps Stanford scientists discover a “natural Ozempic” with a surprising advantage

Stanford researchers identified BRP, a natural peptide that reduced food intake by up to 50 percent in animal tests. The molecule acts selectively on the hypothalamus and promotes fat loss without the muscle loss or digestive side effects observed with semaglutide. This provides a different biological target for teams developing obesity treatments.

Summary written by AI Business Lens with an AI model from the article at sciencedaily.com. It is not the article, and the publisher has not reviewed it. For publishers.

Read the original at sciencedaily.com   Generate teaching or study materials

Instructors get discussion guides, assignments, and mini-cases. Students and readers get a plain summary, points to raise, an exercise, and a self-check. All built from the full article. A free account saves stories and gives you three generations. Stories stay on the brief for 14 days. After that this page keeps the link to the original.

More in Medicine

• Tell this AI what you want a protein to do—and it designs onePhys.org — Biology · November 4, 2026
• AI uncovers rapid changes in Parkinson's brain signals by separating rhythms from background activityMedical Xpress · November 4, 2026
• Patients want a human in the loop for AI healthcare toolsHealthcare Dive · November 4, 2026
• Palantir cofounder wants a 30,000 monkey farm in the US — because AI jacked up macaque prices by 700% in seven yearsTechRadar · November 3, 2026
• Automated platform optimizes enzyme production using cell-free protein synthesis and AI-driven designPhys.org — Biology · November 3, 2026